PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Max Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.\', \'Peter Munk Cardiac Centre, University Health Network and University of Toronto, Toronto, ON, Canada.\', \'Toronto General Hospital Research Institute, Toronto, ON, Canada.\', \'Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.\', \'Department of Medicine, Division of Respirology, University Health Network, Toronto, ON, Canada.\', \'Faculty of Health Sciences, University of Bristol, Bristol, UK.\', \'Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.\', \'Department of Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, ON, Canada.\', \'Thrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University & Hamilton Health Sciences, Hamilton, ON, Canada.\', \'Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.\', \'Center for Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Division of Internal Medicine, Department of Medicine, McGill University, Montreal, QC, Canada.\', \'Department of Surgery, St Michael\'s Hospital and the University of Toronto, Toronto, ON, Canada.\', \'The University of British Columbia, Vancouver, BC, Canada.\', \'Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael\'s Hospital and Departments of Medicine, Surgery, and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.\', \'Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, Faculty of Medicine, Université Laval, Québec, QC, Canada.\', \'CHU de Québec - Université Laval Research Centre, Population Health and Optimal Health Practices Research Unit, Trauma-Emergency-Critical Care Medicine, Université Laval, Québec, QC, Canada.\', \'Berry Consultants, LLC, Austin, TX, USA.\', \'The Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Medical Research Unit on Clinical Epidemiology, Mexican Social Security Institute, Mexico City, Mexico.\', \'Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.\', \'Ozmosis Research Inc., Toronto, ON, Canada.\', \'Department of Clinical Research, SOCAR Research SA, Nyon, Switzerland.\', \'Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, England.\', \'Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/1740774520943846
?:doi
?:hasPublicationType
?:journal
  • Clinical trials (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32815416
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all